Genitourinary Cancer Archives - Cancer Therapy Advisor

Testicular Cancer Treatment Regimens

November 21, 2019

Get the latest treatment regimens for testicular cancer, including options such as carboplatin, EP + cisplatin, BEP, and VIP.

Genitourinary Cancer Treatment Regimens

Prostate Cancer Treatment Regimens

October 25, 2019

Find detailed treatment options for prostate cancer, including clinical trials and anticancer agents such as docetaxel, prednisone, and sipuleucel-T.

Genitourinary Cancer Treatment Regimens

Renal Cell Carcinoma Treatment Regimens

October 25, 2019

Access a treatment regimen chart with detailed information for renal cell carcinoma, including tyrosine kinase inhibitors and cytokine therapy.

An analysis by members of the FDA showed that time to treatment discontinuation may be a viable end point to assess drug efficacy in the postmarketing setting.

AACR 2019

The Predictive Ability of a Cancer Subtype Ontology Assignment

By

Susan Moench, PhD, PA-C

April 3, 2019

The Cancer Subtype Ontology resource includes 840 different cancer subtypes, many of which are novel.

Trade-offs should be carefully considered, as data have indicated that many QoL factors eventually e

Prostate Cancer

Men With Prostate Cancer Willing to Accept Worse Survival Odds to Improve QoL

By

Leah Lawrence

November 27, 2018

Trade-offs should be carefully considered, as data have indicated that many QoL factors eventually even out.

Women and men were found to react differently to treatment with chemotherapy, although gender-based

General Oncology

Gender-Based Differences in Chemotherapy: Efficacy and Safety

By

C. Andrew Kistler, MD, PharmD

November 26, 2018

Women and men were found to react differently to treatment with chemotherapy, although gender-based survival differences were not observed.

By way of the TAPUR study, researchers are attempting to evaluate the activity of targeted therapies

General Oncology

Moving Targets: Off-Label Prescribing of Targeted Therapies

By

Charlotte Huff

November 13, 2018

By way of the TAPUR study, researchers are attempting to evaluate the activity of targeted therapies when they are used in an off-label setting.

General Oncology

The Patient Behind the EHR: Oncologists Only See Half the Picture

By

Daniel Vorobiof, MD

November 6, 2018

Dr Vorobiof discusses the importance patient factors that can be missed via standard data collection methods for patients with cancer.

Image-guided microwave ablation of early-stage renal tumors shows promise but a new retrospective st

Renal Cell Carcinoma

Microwave Ablation for Early-Stage Renal Tumors

By

Bryant Furlow

November 6, 2018

Image-guided microwave ablation of early-stage renal tumors shows promise but a new retrospective study from the Mayo Clinic found some cases of major bleeding.

A patient consultation regarding course of treatment.

Prostate Cancer

Prognostic Model for Survival in Metastatic Prostate Cancer

By

Alexander M. Castellino, PhD

October 31, 2018

Utilizing data from the PREVAIL dataset, researchers developed mathematical models that can provide prognostic information for men being treated with enzalutamide for chemotherapy-naïve metastatic castration-resistant prostate cancer.